India's sixth largest publicly traded drug maker by sales, Wockhardt Ltd, has informed that it will be launching Levetiracetam tablets in the United States.

Recently, Wockhardt Limited has secured nod from the United States Food & Drug Administration (USFDA) for marketing the tablets containing 250mg, 500mg, 750mg and
1gm.

Levetiracetam is an anticonvulsant drug used for the treatment of epilepsy. It is S- enantiomer of etiracetam, structurally similar to the prototypical nootropic drug piracetam.

Total annual market for these drugs, the generic equivalent of UCB Inc.'s Keppra pills, were $1.07 billion.